10x Genomics Inc Class A is a company in the U.S. stock market and it is a holding in 102 U.S.-traded ETFs. TXG has around 8.8M shares in the U.S. ETF market. The largest ETF holder of TXG is the ARK Innovation ETF (ARKK), with approximately 2.33M shares. Investors may also find of interest that the ETF with the largest allocation to TXG stock is Renaissance IPO ETF (IPO), with a portfolio weight of 2.88%. On average, U.S. ETFs allocate 0.39% of TXG to their portfolios.
Additionally, TXG is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with TXG as a holding is the Invesco RAFI Strategic US Small Company ETF (IUSS), with a return of 69.76%.